Connection

Co-Authors

This is a "connection" page, showing publications co-authored by KEVIN GAREY and NICHOLAS BEYDA.
Connection Strength

3.942
  1. Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates. Antimicrob Agents Chemother. 2015 Sep; 59(9):5405-12.
    View in: PubMed
    Score: 0.522
  2. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clin Infect Dis. 2014 Sep 15; 59(6):819-25.
    View in: PubMed
    Score: 0.485
  3. Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samples. Diagn Microbiol Infect Dis. 2013 Dec; 77(4):324-6.
    View in: PubMed
    Score: 0.464
  4. Treatment of Candida famata bloodstream infections: case series and review of the literature. J Antimicrob Chemother. 2013 Feb; 68(2):438-43.
    View in: PubMed
    Score: 0.433
  5. Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches. Ann Pharmacother. 2012 Jul-Aug; 46(7-8):1086-96.
    View in: PubMed
    Score: 0.426
  6. Micafungin pharmacodynamics predict clinical outcomes in hospitalized patients with candidemia caused by certain Candida species. Pharmacotherapy. 2023 06; 43(6):466-472.
    View in: PubMed
    Score: 0.225
  7. Development of the invasive candidiasis discharge [I Can discharge] model: a mixed methods analysis. Eur J Clin Microbiol Infect Dis. 2022 Oct; 41(10):1207-1213.
    View in: PubMed
    Score: 0.214
  8. A Vancomycin HPLC Assay for Use in Gut Microbiome Research. Microbiol Spectr. 2022 06 29; 10(3):e0168821.
    View in: PubMed
    Score: 0.210
  9. In Vitro Evaluation of BacT/Alert FA Blood Culture Bottles and T2Candida Assay for Detection of Candida in the Presence of Antifungals. J Clin Microbiol. 2018 08; 56(8).
    View in: PubMed
    Score: 0.162
  10. Prevalence and predictors of spontaneous bacterial peritonitis due to ceftriaxone-resistant organisms at a large tertiary centre in the USA. J Glob Antimicrob Resist. 2018 12; 15:41-47.
    View in: PubMed
    Score: 0.160
  11. Rezafungin (CD101), a next-generation echinocandin: A systematic literature review and assessment of possible place in therapy. J Glob Antimicrob Resist. 2018 09; 14:58-64.
    View in: PubMed
    Score: 0.157
  12. Echinocandin use in hospitalized patients: a multi-institutional study. Am J Med Sci. 2015 Apr; 349(4):316-20.
    View in: PubMed
    Score: 0.128
  13. Host factors and clinical outcomes of Candida colonization in critically ill patients. Mycopathologia. 2015 Feb; 179(1-2):87-93.
    View in: PubMed
    Score: 0.123
  14. Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics. Ann Pharmacother. 2014 Jun; 48(6):683-90.
    View in: PubMed
    Score: 0.120
  15. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy. J Hosp Infect. 2013 Sep; 85(1):28-32.
    View in: PubMed
    Score: 0.114
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.